AMGEN INC
AMGEN INC
Share · US0311621009 · AMGN · 867900 (XNAS)
Overview Financial Indicators
291,50 USD
0,30 % 0,86 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
06.06.2025 21:41

Current Prices from AMGEN INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
AMGN
USD
06.06.2025 21:41
291,50 USD
287,10 USD
+1,53 %
XETR: XETRA
XETRA
AMG.DE
EUR
06.06.2025 15:35
255,15 EUR
254,60 EUR
+0,22 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 2,10 % 7,79 % -8,41 % 6,91 % -5,06 % 29,17 %

Company Profile for AMGEN INC Share

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Invested Funds

The following funds have invested in: AMGEN INC invested:

Fund
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. in million
2.953,80
Percentage (%)
6,93 %
Fund
iShares Dow Jones Industrial Average UCITS ETF (DE)
Vol. in million
11.287,43
Percentage (%)
4,18 %
Fund
iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)
Vol. in million
5.880,99
Percentage (%)
1,71 %
Fund
iShares MSCI USA SRI UCITS ETF USD (Dist)
Vol. in million
6.933,02
Percentage (%)
1,71 %
Fund
iShares MSCI World Health Care Sector UCITS ETF USD (Dist)
Vol. in million
6.068,54
Percentage (%)
1,66 %

Company Data

Name AMGEN INC
Company Amgen Inc.
Symbol AMGN
Website https://www.amgen.com
Primary Exchange XNAS NASDAQ
WKN 867900
ISIN US0311621009
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - General
CEO Mr. Robert A. Bradway
Market Capitalization 130 Mrd.
Country United States of America
Currency USD
Employees 28,0 T
Address One Amgen Center Drive, 91320-1799 Thousand Oaks
IPO Date 2000-01-03
Dividends from 'AMGEN INC'
Ex-Date Dividend per Share
16.05.2025 2,38 USD
14.02.2025 2,38 USD
18.11.2024 2,25 USD
16.08.2024 2,25 USD
16.05.2024 2,25 USD
15.02.2024 2,25 USD
16.11.2023 2,13 USD
17.08.2023 2,13 USD
17.05.2023 2,13 USD
14.02.2023 2,13 USD

Stock Splits

Date Split
22.11.1999 2:1
01.03.1999 2:1
16.08.1995 2:1
11.09.1991 3:1
13.08.1990 2:1

Ticker Symbols

Name Symbol
Frankfurt AMG.F
NASDAQ AMGN
XETRA AMG.DE

More Shares

Investors who AMGEN INC hold also have the following shares in their portfolio:
ADOBE INC
ADOBE INC Share
ALLIANZ AG
ALLIANZ AG Share
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Share
AMAZON.CO INC
AMAZON.CO INC Share
APPLE INC
APPLE INC Share
ASTRAZENECA PLC - AMERICAN DEPOSITARY SHARES
ASTRAZENECA PLC - AMERICAN DEPOSITARY SHARES Depository Receipt
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
INTEL CORP
INTEL CORP Share
ISHSII-MSCI EUR.SRI EOACC
ISHSII-MSCI EUR.SRI EOACC ETF
MICROSOFT CORP
MICROSOFT CORP Share
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Share
ROCHE KAPITALMKT 18-25
ROCHE KAPITALMKT 18-25 Bond
TEXAS INSTRUMENTS INC
TEXAS INSTRUMENTS INC Share
TOLL BROTHERS
TOLL BROTHERS Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025